HomeRegisterSearchToolsHelp

Featured Article

Reboussin DM, Allen NB, Griswold ME, et al. Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 May 15;71(19):2176-2198. doi: 10.1016/j.jacc.2017.11.004. Epub 2017 Nov 13. (Review) PMID: 29146534
DynaMed Plus
Read Abstract Read Comments Evidence-Based Guideline      
DISCIPLINERELEVANCE TO PRACTICEIS THIS NEWS?
Internal Medicine
Public Health
Cardiology
Family Medicine (FM)/General Practice (GP)
General Internal Medicine-Primary Care(US)

Print             Email this article to a colleague     Share on Facebook   Follow me on Tweeter   Share on Del.icio.us   Share on Reddit   Share on Digg   Share on CiteULike


Abstract

OBJECTIVE: To review the literature systematically and perform meta-analyses to address these questions: 1) Is there evidence that self-measured blood pressure (BP) without other augmentation is superior to office-based measurement of BP for achieving better BP control or for preventing adverse clinical outcomes that are related to elevated BP? 2) What is the optimal target for BP lowering during antihypertensive therapy in adults? 3) In adults with hypertension, how do various antihypertensive drug classes differ in their benefits and harms compared with each other as first-line therapy?

METHODS: Electronic literature searches were performed by Doctor Evidence, a global medical evidence software and services company, across PubMed and EMBASE from 1966 to 2015 using key words and relevant subject headings for randomized controlled trials that met eligibility criteria defined for each question. We performed analyses using traditional frequentist statistical and Bayesian approaches, including random-effects Bayesian network meta-analyses.

RESULTS: Our results suggest that: 1) There is a modest but significant improvement in systolic BP in randomized controlled trials of self-measured BP versus usual care at 6 but not 12 months, and for selected patients and their providers self-measured BP may be a helpful adjunct to routine office care. 2) systolic BP lowering to a target of <130 mm Hg may reduce the risk of several important outcomes including risk of myocardial infarction, stroke, heart failure, and major cardiovascular events. No class of medications (i.e., angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, calcium channel blockers, or beta blockers) was significantly better than thiazides and thiazide-like diuretics as a first-line therapy for any outcome.


Comments from Clinical Raters
General Internal Medicine-Primary Care(US)
Although this is an important finding, the article is way too long to read for a practitioner.
Public Health
Actually, most practitioners probably already know this but it does provide solid, comprehensive evidence in support of the conclusions. Too bad that other questions such as side effects, compliance, etc are not addressed.
Public Health
This is an important report including 3 important systematic reviews addressing the corresponding research questions. All clinicians who care for hypertensive patients should read this report!

Other EBM Resources from McMaster:

NURSING+
REHAB+
ACCESSSS